retatrutide 2025 trial results 💉𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀 𝗨𝗻𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁: 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂 𝗦𝗵𝗼𝘂𝗹𝗱 𝗞𝗻𝗼𝘄 𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲: a new triple-agonist weight loss drug that is STILL IN CLINICAL TRIALS, is showing incredible results, with some 💉 Retatrutide may be redefining

GLP-1s are powerful medications and should be prescribed only by medical professionals who have completed comprehensive medical assessments, including running labs, adds Zimmermann

Limitations & Considerations Long-term data are limited

The FDA classifies BPC-157 as a Category 2 bulk drug substance meaning its not FDA-approved for human use and has been flagged as potentially presenting safety risks in unregulated compounding

Reduced risk factors for diabetes, high cholesterol, and hypertension

They can control copper, a dangerous but important metal, making them useful for researching tissue healing, oxidative balance, and inflammation